<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Side population (SP) cells and their relationship to stem cell-like properties have been insufficiently studied in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>MicroRNAs (miRNAs) have attracted much attention but their roles in the maintenance of SP phenotype remain unclear </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The SPs from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines and primary cell cultures were analysed for stem cell-like properties </plain></SENT>
<SENT sid="3" pm="."><plain>MiRNA microarray analysis identified miR-328 as a potential stemness miRNA of SP phenotype </plain></SENT>
<SENT sid="4" pm="."><plain>The level of miR-328 expression in clinical samples and its correlation with SP fraction were determined </plain></SENT>
<SENT sid="5" pm="."><plain>Gain-of-function and loss-of-function studies were performed to examine its roles in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem-like SP cells </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, bioinformatics prediction and experimental validation were used to identify miR-328 target genes </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The SP cells sorted from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> possess <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell (<z:chebi fb="11" ids="17437,53115">CSC</z:chebi>)-like properties, including self-renewal, differentiation, resistance to chemotherapy, invasive and strong <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> formation ability </plain></SENT>
<SENT sid="8" pm="."><plain>MiR-328 expression was significantly reduced in SP cells compared with Non-SP cells (P&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, miR-328 expression was downregulated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (n=33, P&lt;0.05) and low miR-328 expression tend to correlate with high SP fraction (n=15, r=0.6559, P&lt;0.05, Pearson's correlation) </plain></SENT>
<SENT sid="10" pm="."><plain>Functional studies indicated that miR-328 expression affects the number of SP cells </plain></SENT>
<SENT sid="11" pm="."><plain>In addition, miR-328 overexpression reversed drug resistance and inhibited cell invasion of SP cells </plain></SENT>
<SENT sid="12" pm="."><plain>Furthermore, luciferase reporter assay demonstrated that miR-328 directly targets ABCG2 and MMP16 and affects the levels of <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression in SP cells </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: These findings indicate that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> contain <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem-like SP cells </plain></SENT>
<SENT sid="14" pm="."><plain>MiR-328 has an important role in maintaining <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem-like SP phenotype that may be a potential target for effective <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> therapy </plain></SENT>
</text></document>